PubMed:9592127 / 135-520 JSONTXT

{"project":"Glycosmos15-CL","denotations":[{"id":"T2","span":{"begin":353,"end":357},"obj":"Cell"}],"attributes":[{"id":"A2","pred":"cl_id","subj":"T2","obj":"http://purl.obolibrary.org/obo/CL:0000096"},{"id":"A3","pred":"cl_id","subj":"T2","obj":"http://purl.obolibrary.org/obo/CL:0000775"}],"text":"Human pancreatic cancer is characterized by an alteration in fucose-containing surface blood group antigens such as H antigen, Lewis b, Lewis y, and sialyl-Lewis. These carbohydrate determinants can be synthesized by sequential action of alpha(2,3) sialyltransferases or alpha(1,2) fucosyltransferases (Fuc-T) and alpha(1,3/1,4) fucosyltransferases on (poly)N-acetyllactosamine chains."}

{"project":"Glycan-Motif","denotations":[{"id":"T1","span":{"begin":61,"end":67},"obj":"https://glytoucan.org/Structures/Glycans/G82576YO"},{"id":"T2","span":{"begin":116,"end":125},"obj":"https://glytoucan.org/Structures/Glycans/G46868TY"},{"id":"T3","span":{"begin":127,"end":134},"obj":"https://glytoucan.org/Structures/Glycans/G00048MO"},{"id":"T4","span":{"begin":127,"end":134},"obj":"https://glytoucan.org/Structures/Glycans/G39211DH"},{"id":"T5","span":{"begin":136,"end":143},"obj":"https://glytoucan.org/Structures/Glycans/G00052MO"},{"id":"T6","span":{"begin":358,"end":377},"obj":"https://glytoucan.org/Structures/Glycans/G00055MO"}],"text":"Human pancreatic cancer is characterized by an alteration in fucose-containing surface blood group antigens such as H antigen, Lewis b, Lewis y, and sialyl-Lewis. These carbohydrate determinants can be synthesized by sequential action of alpha(2,3) sialyltransferases or alpha(1,2) fucosyltransferases (Fuc-T) and alpha(1,3/1,4) fucosyltransferases on (poly)N-acetyllactosamine chains."}

{"project":"GlyCosmos6-Glycan-Motif-Image","denotations":[{"id":"T1","span":{"begin":61,"end":67},"obj":"Glycan_Motif"},{"id":"T2","span":{"begin":116,"end":125},"obj":"Glycan_Motif"},{"id":"T3","span":{"begin":127,"end":134},"obj":"Glycan_Motif"},{"id":"T5","span":{"begin":136,"end":143},"obj":"Glycan_Motif"},{"id":"T6","span":{"begin":358,"end":377},"obj":"Glycan_Motif"}],"attributes":[{"id":"A1","pred":"image","subj":"T1","obj":"https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G82576YO"},{"id":"A2","pred":"image","subj":"T2","obj":"https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G46868TY"},{"id":"A3","pred":"image","subj":"T3","obj":"https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G39211DH"},{"id":"A4","pred":"image","subj":"T3","obj":"https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G00048MO"},{"id":"A5","pred":"image","subj":"T5","obj":"https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G00052MO"},{"id":"A6","pred":"image","subj":"T6","obj":"https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G00055MO"}],"text":"Human pancreatic cancer is characterized by an alteration in fucose-containing surface blood group antigens such as H antigen, Lewis b, Lewis y, and sialyl-Lewis. These carbohydrate determinants can be synthesized by sequential action of alpha(2,3) sialyltransferases or alpha(1,2) fucosyltransferases (Fuc-T) and alpha(1,3/1,4) fucosyltransferases on (poly)N-acetyllactosamine chains."}

{"project":"sentences","denotations":[{"id":"TextSentencer_T2","span":{"begin":0,"end":162},"obj":"Sentence"},{"id":"TextSentencer_T3","span":{"begin":163,"end":385},"obj":"Sentence"},{"id":"T2","span":{"begin":0,"end":385},"obj":"Sentence"},{"id":"T2","span":{"begin":0,"end":162},"obj":"Sentence"},{"id":"T3","span":{"begin":163,"end":385},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Human pancreatic cancer is characterized by an alteration in fucose-containing surface blood group antigens such as H antigen, Lewis b, Lewis y, and sialyl-Lewis. These carbohydrate determinants can be synthesized by sequential action of alpha(2,3) sialyltransferases or alpha(1,2) fucosyltransferases (Fuc-T) and alpha(1,3/1,4) fucosyltransferases on (poly)N-acetyllactosamine chains."}

{"project":"GlyCosmos6-Glycan-Motif-Structure","denotations":[{"id":"T1","span":{"begin":61,"end":67},"obj":"https://glytoucan.org/Structures/Glycans/G82576YO"},{"id":"T2","span":{"begin":116,"end":125},"obj":"https://glytoucan.org/Structures/Glycans/G46868TY"},{"id":"T3","span":{"begin":127,"end":134},"obj":"https://glytoucan.org/Structures/Glycans/G00048MO"},{"id":"T4","span":{"begin":127,"end":134},"obj":"https://glytoucan.org/Structures/Glycans/G39211DH"},{"id":"T5","span":{"begin":136,"end":143},"obj":"https://glytoucan.org/Structures/Glycans/G00052MO"},{"id":"T6","span":{"begin":358,"end":377},"obj":"https://glytoucan.org/Structures/Glycans/G00055MO"}],"text":"Human pancreatic cancer is characterized by an alteration in fucose-containing surface blood group antigens such as H antigen, Lewis b, Lewis y, and sialyl-Lewis. These carbohydrate determinants can be synthesized by sequential action of alpha(2,3) sialyltransferases or alpha(1,2) fucosyltransferases (Fuc-T) and alpha(1,3/1,4) fucosyltransferases on (poly)N-acetyllactosamine chains."}

{"project":"Glycosmos6-GlycoEpitope","denotations":[{"id":"T1","span":{"begin":127,"end":134},"obj":"http://www.glycoepitope.jp/epitopes/EP0010"},{"id":"T2","span":{"begin":136,"end":143},"obj":"http://www.glycoepitope.jp/epitopes/EP0018"}],"text":"Human pancreatic cancer is characterized by an alteration in fucose-containing surface blood group antigens such as H antigen, Lewis b, Lewis y, and sialyl-Lewis. These carbohydrate determinants can be synthesized by sequential action of alpha(2,3) sialyltransferases or alpha(1,2) fucosyltransferases (Fuc-T) and alpha(1,3/1,4) fucosyltransferases on (poly)N-acetyllactosamine chains."}

{"project":"Glycosmos6-MAT","denotations":[{"id":"T1","span":{"begin":87,"end":92},"obj":"http://purl.obolibrary.org/obo/MAT_0000083"},{"id":"T2","span":{"begin":87,"end":92},"obj":"http://purl.obolibrary.org/obo/MAT_0000315"}],"text":"Human pancreatic cancer is characterized by an alteration in fucose-containing surface blood group antigens such as H antigen, Lewis b, Lewis y, and sialyl-Lewis. These carbohydrate determinants can be synthesized by sequential action of alpha(2,3) sialyltransferases or alpha(1,2) fucosyltransferases (Fuc-T) and alpha(1,3/1,4) fucosyltransferases on (poly)N-acetyllactosamine chains."}

{"project":"GlycoBiology-FMA","denotations":[{"id":"_T3","span":{"begin":61,"end":67},"obj":"FMAID:196784"},{"id":"_T4","span":{"begin":61,"end":67},"obj":"FMAID:82790"},{"id":"_T5","span":{"begin":79,"end":86},"obj":"FMAID:146300"},{"id":"_T6","span":{"begin":79,"end":86},"obj":"FMAID:50594"},{"id":"_T7","span":{"begin":87,"end":92},"obj":"FMAID:256053"},{"id":"_T8","span":{"begin":169,"end":181},"obj":"FMAID:82737"},{"id":"_T9","span":{"begin":169,"end":181},"obj":"FMAID:197276"},{"id":"_T10","span":{"begin":358,"end":377},"obj":"FMAID:196780"},{"id":"_T11","span":{"begin":358,"end":377},"obj":"FMAID:82786"}],"namespaces":[{"prefix":"FMAID","uri":"http://purl.org/sig/ont/fma/fma"}],"text":"Human pancreatic cancer is characterized by an alteration in fucose-containing surface blood group antigens such as H antigen, Lewis b, Lewis y, and sialyl-Lewis. These carbohydrate determinants can be synthesized by sequential action of alpha(2,3) sialyltransferases or alpha(1,2) fucosyltransferases (Fuc-T) and alpha(1,3/1,4) fucosyltransferases on (poly)N-acetyllactosamine chains."}

{"project":"GlycoBiology-NCBITAXON","denotations":[{"id":"T4","span":{"begin":17,"end":23},"obj":"http://purl.bioontology.org/ontology/NCBITAXON/6754"},{"id":"T5","span":{"begin":93,"end":98},"obj":"http://purl.bioontology.org/ontology/STY/T096"}],"text":"Human pancreatic cancer is characterized by an alteration in fucose-containing surface blood group antigens such as H antigen, Lewis b, Lewis y, and sialyl-Lewis. These carbohydrate determinants can be synthesized by sequential action of alpha(2,3) sialyltransferases or alpha(1,2) fucosyltransferases (Fuc-T) and alpha(1,3/1,4) fucosyltransferases on (poly)N-acetyllactosamine chains."}

{"project":"GO-BP","denotations":[{"id":"T3","span":{"begin":149,"end":155},"obj":"http://purl.obolibrary.org/obo/GO_0097503"},{"id":"T10","span":{"begin":271,"end":301},"obj":"http://purl.obolibrary.org/obo/GO_0031127"}],"text":"Human pancreatic cancer is characterized by an alteration in fucose-containing surface blood group antigens such as H antigen, Lewis b, Lewis y, and sialyl-Lewis. These carbohydrate determinants can be synthesized by sequential action of alpha(2,3) sialyltransferases or alpha(1,2) fucosyltransferases (Fuc-T) and alpha(1,3/1,4) fucosyltransferases on (poly)N-acetyllactosamine chains."}

{"project":"UBERON-AE","denotations":[{"id":"T11","span":{"begin":87,"end":92},"obj":"http://purl.obolibrary.org/obo/UBERON_0000178"}],"text":"Human pancreatic cancer is characterized by an alteration in fucose-containing surface blood group antigens such as H antigen, Lewis b, Lewis y, and sialyl-Lewis. These carbohydrate determinants can be synthesized by sequential action of alpha(2,3) sialyltransferases or alpha(1,2) fucosyltransferases (Fuc-T) and alpha(1,3/1,4) fucosyltransferases on (poly)N-acetyllactosamine chains."}

{"project":"GlycoBiology-MAT","denotations":[{"id":"T1","span":{"begin":87,"end":92},"obj":"http://purl.obolibrary.org/obo/MAT_0000083"},{"id":"T2","span":{"begin":87,"end":92},"obj":"http://purl.obolibrary.org/obo/MAT_0000315"}],"text":"Human pancreatic cancer is characterized by an alteration in fucose-containing surface blood group antigens such as H antigen, Lewis b, Lewis y, and sialyl-Lewis. These carbohydrate determinants can be synthesized by sequential action of alpha(2,3) sialyltransferases or alpha(1,2) fucosyltransferases (Fuc-T) and alpha(1,3/1,4) fucosyltransferases on (poly)N-acetyllactosamine chains."}

{"project":"GlycoBiology-Motifs","denotations":[{"id":"T1","span":{"begin":87,"end":98},"obj":"http://rdf.glycoinfo.org/glycan/G00066MO"},{"id":"T2","span":{"begin":127,"end":132},"obj":"http://rdf.glycoinfo.org/glycan/G00047MO"},{"id":"T3","span":{"begin":136,"end":141},"obj":"http://rdf.glycoinfo.org/glycan/G00047MO"},{"id":"T4","span":{"begin":156,"end":161},"obj":"http://rdf.glycoinfo.org/glycan/G00047MO"},{"id":"T13","span":{"begin":127,"end":134},"obj":"http://rdf.glycoinfo.org/glycan/G00048MO"},{"id":"T14","span":{"begin":136,"end":143},"obj":"http://rdf.glycoinfo.org/glycan/G00052MO"},{"id":"T16","span":{"begin":149,"end":161},"obj":"http://rdf.glycoinfo.org/glycan/G00053MO"}],"text":"Human pancreatic cancer is characterized by an alteration in fucose-containing surface blood group antigens such as H antigen, Lewis b, Lewis y, and sialyl-Lewis. These carbohydrate determinants can be synthesized by sequential action of alpha(2,3) sialyltransferases or alpha(1,2) fucosyltransferases (Fuc-T) and alpha(1,3/1,4) fucosyltransferases on (poly)N-acetyllactosamine chains."}

{"project":"GlycoBiology-Epitope","denotations":[{"id":"PD-GlycoEpitope-B_T8","span":{"begin":149,"end":161},"obj":"http://www.glycoepitope.jp/epitopes/EP0008"},{"id":"PD-GlycoEpitope-B_T17","span":{"begin":136,"end":143},"obj":"http://www.glycoepitope.jp/epitopes/EP0018"},{"id":"PD-GlycoEpitope-B_T19","span":{"begin":127,"end":134},"obj":"http://www.glycoepitope.jp/epitopes/EP0010"}],"text":"Human pancreatic cancer is characterized by an alteration in fucose-containing surface blood group antigens such as H antigen, Lewis b, Lewis y, and sialyl-Lewis. These carbohydrate determinants can be synthesized by sequential action of alpha(2,3) sialyltransferases or alpha(1,2) fucosyltransferases (Fuc-T) and alpha(1,3/1,4) fucosyltransferases on (poly)N-acetyllactosamine chains."}

{"project":"GlyTouCan-IUPAC","denotations":[{"id":"GlycanIUPAC_T1","span":{"begin":303,"end":306},"obj":"\"http://rdf.glycoinfo.org/glycan/G49112ZN\""},{"id":"GlycanIUPAC_T10","span":{"begin":303,"end":306},"obj":"\"http://rdf.glycoinfo.org/glycan/G50059AJ\""},{"id":"GlycanIUPAC_T19","span":{"begin":303,"end":306},"obj":"\"http://rdf.glycoinfo.org/glycan/G76218YK\""},{"id":"GlycanIUPAC_T28","span":{"begin":303,"end":306},"obj":"\"http://rdf.glycoinfo.org/glycan/G50102KR\""},{"id":"GlycanIUPAC_T37","span":{"begin":303,"end":306},"obj":"\"http://rdf.glycoinfo.org/glycan/G10717VS\""},{"id":"GlycanIUPAC_T46","span":{"begin":303,"end":306},"obj":"\"http://rdf.glycoinfo.org/glycan/G60524RK\""},{"id":"GlycanIUPAC_T55","span":{"begin":303,"end":306},"obj":"\"http://rdf.glycoinfo.org/glycan/G84407TT\""},{"id":"GlycanIUPAC_T64","span":{"begin":303,"end":306},"obj":"\"http://rdf.glycoinfo.org/glycan/G64717JT\""},{"id":"GlycanIUPAC_T73","span":{"begin":303,"end":306},"obj":"\"http://rdf.glycoinfo.org/glycan/G45003TT\""},{"id":"GlycanIUPAC_T82","span":{"begin":303,"end":306},"obj":"\"http://rdf.glycoinfo.org/glycan/G73923FP\""},{"id":"GlycanIUPAC_T91","span":{"begin":303,"end":306},"obj":"\"http://rdf.glycoinfo.org/glycan/G78231MB\""},{"id":"GlycanIUPAC_T100","span":{"begin":303,"end":306},"obj":"\"http://rdf.glycoinfo.org/glycan/G80487UG\""},{"id":"GlycanIUPAC_T109","span":{"begin":303,"end":306},"obj":"\"http://rdf.glycoinfo.org/glycan/G29758MI\""},{"id":"GlycanIUPAC_T118","span":{"begin":303,"end":306},"obj":"\"http://rdf.glycoinfo.org/glycan/G02671KD\""},{"id":"GlycanIUPAC_T127","span":{"begin":303,"end":306},"obj":"\"http://rdf.glycoinfo.org/glycan/G57926TZ\""},{"id":"GlycanIUPAC_T136","span":{"begin":303,"end":306},"obj":"\"http://rdf.glycoinfo.org/glycan/G41718FD\""},{"id":"GlycanIUPAC_T145","span":{"begin":303,"end":306},"obj":"\"http://rdf.glycoinfo.org/glycan/G99840FL\""},{"id":"GlycanIUPAC_T154","span":{"begin":303,"end":306},"obj":"\"http://rdf.glycoinfo.org/glycan/G64321UX\""},{"id":"GlycanIUPAC_T163","span":{"begin":303,"end":306},"obj":"\"http://rdf.glycoinfo.org/glycan/G11231EG\""},{"id":"GlycanIUPAC_T172","span":{"begin":303,"end":306},"obj":"\"http://rdf.glycoinfo.org/glycan/G62741TN\""},{"id":"GlycanIUPAC_T181","span":{"begin":303,"end":306},"obj":"\"http://rdf.glycoinfo.org/glycan/G51576ZQ\""},{"id":"GlycanIUPAC_T190","span":{"begin":303,"end":306},"obj":"\"http://rdf.glycoinfo.org/glycan/G66056LD\""},{"id":"GlycanIUPAC_T199","span":{"begin":303,"end":306},"obj":"\"http://rdf.glycoinfo.org/glycan/G02768BF\""},{"id":"GlycanIUPAC_T208","span":{"begin":303,"end":306},"obj":"\"http://rdf.glycoinfo.org/glycan/G26168RO\""},{"id":"GlycanIUPAC_T217","span":{"begin":303,"end":306},"obj":"\"http://rdf.glycoinfo.org/glycan/G42890HL\""},{"id":"GlycanIUPAC_T226","span":{"begin":303,"end":306},"obj":"\"http://rdf.glycoinfo.org/glycan/G17533VU\""},{"id":"GlycanIUPAC_T235","span":{"begin":303,"end":306},"obj":"\"http://rdf.glycoinfo.org/glycan/G34306RG\""},{"id":"GlycanIUPAC_T244","span":{"begin":303,"end":306},"obj":"\"http://rdf.glycoinfo.org/glycan/G88735KU\""},{"id":"GlycanIUPAC_T253","span":{"begin":303,"end":306},"obj":"\"http://rdf.glycoinfo.org/glycan/G82605UA\""}],"text":"Human pancreatic cancer is characterized by an alteration in fucose-containing surface blood group antigens such as H antigen, Lewis b, Lewis y, and sialyl-Lewis. These carbohydrate determinants can be synthesized by sequential action of alpha(2,3) sialyltransferases or alpha(1,2) fucosyltransferases (Fuc-T) and alpha(1,3/1,4) fucosyltransferases on (poly)N-acetyllactosamine chains."}

{"project":"performance-test","denotations":[{"id":"PD-UBERON-AE-B_T11","span":{"begin":87,"end":92},"obj":"http://purl.obolibrary.org/obo/UBERON_0000178"}],"text":"Human pancreatic cancer is characterized by an alteration in fucose-containing surface blood group antigens such as H antigen, Lewis b, Lewis y, and sialyl-Lewis. These carbohydrate determinants can be synthesized by sequential action of alpha(2,3) sialyltransferases or alpha(1,2) fucosyltransferases (Fuc-T) and alpha(1,3/1,4) fucosyltransferases on (poly)N-acetyllactosamine chains."}

{"project":"mondo_disease","denotations":[{"id":"T2","span":{"begin":6,"end":23},"obj":"Disease"}],"attributes":[{"id":"A2","pred":"mondo_id","subj":"T2","obj":"http://purl.obolibrary.org/obo/MONDO_0005192"},{"id":"A3","pred":"mondo_id","subj":"T2","obj":"http://purl.obolibrary.org/obo/MONDO_0009831"}],"text":"Human pancreatic cancer is characterized by an alteration in fucose-containing surface blood group antigens such as H antigen, Lewis b, Lewis y, and sialyl-Lewis. These carbohydrate determinants can be synthesized by sequential action of alpha(2,3) sialyltransferases or alpha(1,2) fucosyltransferases (Fuc-T) and alpha(1,3/1,4) fucosyltransferases on (poly)N-acetyllactosamine chains."}

{"project":"GlyCosmos15-HP","denotations":[{"id":"T2","span":{"begin":6,"end":23},"obj":"Phenotype"}],"attributes":[{"id":"A2","pred":"hp_id","subj":"T2","obj":"HP:0002894"}],"namespaces":[{"prefix":"HP","uri":"http://purl.obolibrary.org/obo/HP_"}],"text":"Human pancreatic cancer is characterized by an alteration in fucose-containing surface blood group antigens such as H antigen, Lewis b, Lewis y, and sialyl-Lewis. These carbohydrate determinants can be synthesized by sequential action of alpha(2,3) sialyltransferases or alpha(1,2) fucosyltransferases (Fuc-T) and alpha(1,3/1,4) fucosyltransferases on (poly)N-acetyllactosamine chains."}

{"project":"GlyCosmos15-Glycan","denotations":[{"id":"T1","span":{"begin":127,"end":134},"obj":"Glycan"},{"id":"T2","span":{"begin":136,"end":143},"obj":"Glycan"}],"attributes":[{"id":"A1","pred":"glycosmos_id","subj":"T1","obj":"https://glycosmos.org/glycans/show/G00048MO"},{"id":"A11","pred":"image","subj":"T1","obj":"https://api.glycosmos.org/wurcs2image/latest/png/binary/G00048MO"},{"id":"A2","pred":"glycosmos_id","subj":"T2","obj":"https://glycosmos.org/glycans/show/G00052MO"},{"id":"A12","pred":"image","subj":"T2","obj":"https://api.glycosmos.org/wurcs2image/latest/png/binary/G00052MO"}],"text":"Human pancreatic cancer is characterized by an alteration in fucose-containing surface blood group antigens such as H antigen, Lewis b, Lewis y, and sialyl-Lewis. These carbohydrate determinants can be synthesized by sequential action of alpha(2,3) sialyltransferases or alpha(1,2) fucosyltransferases (Fuc-T) and alpha(1,3/1,4) fucosyltransferases on (poly)N-acetyllactosamine chains."}

{"project":"NCBITAXON","denotations":[{"id":"T2","span":{"begin":0,"end":5},"obj":"OrganismTaxon"}],"attributes":[{"id":"A2","pred":"db_id","subj":"T2","obj":"9606"}],"text":"Human pancreatic cancer is characterized by an alteration in fucose-containing surface blood group antigens such as H antigen, Lewis b, Lewis y, and sialyl-Lewis. These carbohydrate determinants can be synthesized by sequential action of alpha(2,3) sialyltransferases or alpha(1,2) fucosyltransferases (Fuc-T) and alpha(1,3/1,4) fucosyltransferases on (poly)N-acetyllactosamine chains."}

{"project":"Glycosmos15-GlycoEpitope","denotations":[{"id":"T1","span":{"begin":127,"end":134},"obj":"http://purl.jp/bio/12/glyco/glycan#Glycan_epitope"},{"id":"T2","span":{"begin":136,"end":143},"obj":"http://purl.jp/bio/12/glyco/glycan#Glycan_epitope"}],"attributes":[{"id":"A1","pred":"glycoepitope_id","subj":"T1","obj":"http://www.glycoepitope.jp/epitopes/EP0010"},{"id":"A2","pred":"glycoepitope_id","subj":"T2","obj":"http://www.glycoepitope.jp/epitopes/EP0018"}],"text":"Human pancreatic cancer is characterized by an alteration in fucose-containing surface blood group antigens such as H antigen, Lewis b, Lewis y, and sialyl-Lewis. These carbohydrate determinants can be synthesized by sequential action of alpha(2,3) sialyltransferases or alpha(1,2) fucosyltransferases (Fuc-T) and alpha(1,3/1,4) fucosyltransferases on (poly)N-acetyllactosamine chains."}

{"project":"Anatomy-UBERON","denotations":[{"id":"T2","span":{"begin":87,"end":92},"obj":"Body_part"}],"attributes":[{"id":"A2","pred":"uberon_id","subj":"T2","obj":"http://purl.obolibrary.org/obo/UBERON_0000178"}],"text":"Human pancreatic cancer is characterized by an alteration in fucose-containing surface blood group antigens such as H antigen, Lewis b, Lewis y, and sialyl-Lewis. These carbohydrate determinants can be synthesized by sequential action of alpha(2,3) sialyltransferases or alpha(1,2) fucosyltransferases (Fuc-T) and alpha(1,3/1,4) fucosyltransferases on (poly)N-acetyllactosamine chains."}

{"project":"Anatomy-MAT","denotations":[{"id":"T1","span":{"begin":87,"end":92},"obj":"Body_part"}],"attributes":[{"id":"A1","pred":"mat_id","subj":"T1","obj":"http://purl.obolibrary.org/obo/MAT_0000083"},{"id":"A2","pred":"mat_id","subj":"T1","obj":"http://purl.obolibrary.org/obo/MAT_0000315"}],"text":"Human pancreatic cancer is characterized by an alteration in fucose-containing surface blood group antigens such as H antigen, Lewis b, Lewis y, and sialyl-Lewis. These carbohydrate determinants can be synthesized by sequential action of alpha(2,3) sialyltransferases or alpha(1,2) fucosyltransferases (Fuc-T) and alpha(1,3/1,4) fucosyltransferases on (poly)N-acetyllactosamine chains."}